Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31 Mar 2020

DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2020
Quarter 1 Qtr
Quarterly report for the financial period ended 31 Mar 2020
The figures have not been audited
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2020

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Mar 2020
31 Mar 2019
31 Mar 2020
31 Mar 2019
$$'000
$$'000
$$'000
$$'000
1 Revenue
158,713
150,386
158,713
150,386
2 Profit/(loss) before tax
17,727
18,786
17,727
18,786
3 Profit/(loss) for the period
13,561
14,465
13,561
14,465
4 Profit/(loss) attributable to ordinary equity holders of the parent
13,561
14,465
13,561
14,465
5 Basic earnings/(loss) per share (Subunit)
1.98
2.19
1.98
2.19
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.7900
0.7700

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 18 May 2020
Category Financial Results
Reference Number FRA-06052020-00007